1
|
Punt A, Lautz L, Stoopen G, Pinckaers N, Rijkers D, Essers M, Hoogenboom R. In vitro metabolism of lidocaine in subcellular post-mitochondrial fractions and precision cut slices from cattle liver. Toxicol In Vitro 2021; 76:105228. [PMID: 34311064 DOI: 10.1016/j.tiv.2021.105228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2021] [Revised: 07/06/2021] [Accepted: 07/20/2021] [Indexed: 11/27/2022]
Abstract
In vitro models are widely used to study the biotransformation of xenobiotics and to provide input parameters to physiologically based kinetic models required to predict the kinetic behavior in vivo. For farm animals this is not common practice yet. The use of slaughterhouse-derived tissue material may provide opportunities to study biotransformation reactions in farm animals. The goal of the present study was to explore the potential of slaughterhouse-derived bovine liver S9 (S9) and precision cut liver slices (PCLSs) to capture observed biotransformation reactions of lidocaine in cows. The in vitro data obtained with both S9 and PCLSs confirm in vivo findings that 2,6-dimethylaniline (DMA) is an important metabolite of lidocaine in cows, being for both PCLSs and S9 the end-product. In case of S9, also conversion of lidocaine to lidocaine-N-oxide and monoethylglycinexylidine (MEXG) was observed. MEGX is considered as intermediate for DMA formation, given that this metabolite was metabolized to DMA by both PLCSs and S9. In contrast to in vivo, no in vitro conversion of DMA to 4-OH-DMA was observed. Further work is needed to explain this lack of conversion and to further evaluate the use of slaughterhouse-derived tissue materials to predict the biotransformation of xenobiotics in farm animals.
Collapse
Affiliation(s)
- Ans Punt
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands
| | - Leonie Lautz
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands.
| | - Geert Stoopen
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands
| | - Nicole Pinckaers
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands
| | - Deborah Rijkers
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands
| | - Martien Essers
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands
| | - Ron Hoogenboom
- Wageningen Food Safety Research, Wageningen University and Research, PO Box 230, 6700 AE Wageningen, the Netherlands
| |
Collapse
|
2
|
Wang Y, Ou-Yang QG, Huang WL, Huang HL, Zhuang XL, Lin QM, Zeng DL. Investigation of the Inhibitory Effect of Simvastatin on the Metabolism of Lidocaine Both in vitro and in vivo. Drug Des Devel Ther 2020; 14:1739-1747. [PMID: 32440099 PMCID: PMC7212776 DOI: 10.2147/dddt.s241022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Accepted: 04/09/2020] [Indexed: 12/11/2022]
Abstract
Background Lidocaine has cardiovascular and neurologic toxicity, which is dose-dependent. Due to CYP3A4-involved metabolism, lidocaine may be prone to drug-drug interactions. Materials and Methods Given statins have the possibility of combination with lidocaine in the clinic, we established in vitro models to assess the effect of statins on the metabolism of lidocaine. Further pharmacokinetic alterations of lidocaine and its main metabolite, monoethylglycinexylidide in rats influenced by simvastatin, were investigated. Results In vitro study revealed that simvastatin, among the statins, had the most significant inhibitory effect on lidocaine metabolism with IC50 of 39.31 µM, 50 µM and 15.77 µM for RLM, HLM and CYP3A4.1, respectively. Consistent with in vitro results, lidocaine concomitantly used with simvastatin in rats was associated with 1.2-fold AUC(0-t), 1.2-fold AUC(0-∞), and 20%-decreased clearance for lidocaine, and 1.4-fold Cmax for MEGX compared with lidocaine alone. Conclusion Collectively, these results implied that simvastatin could evidently inhibit the metabolism of lidocaine both in vivo and in vitro. Accordingly, more attention and necessary therapeutic drug monitoring should be paid to patients with the concomitant coadministration of lidocaine and simvastatin so as to avoid unexpected toxicity.
Collapse
Affiliation(s)
- Ying Wang
- Pharmacy Department, Ningbo Medical Center Lihuili Hospital, Ningbo 315000, Zhejiang Province, People's Republic of China
| | - Qiu-Geng Ou-Yang
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, People's Republic of China
| | - Wan-Li Huang
- School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province,People's Republic of China
| | - Huan-le Huang
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, People's Republic of China.,Department of Pharmacy, Ruian Hospital of Traditional Chinese Medicine, Wenzhou 325000, Zhejiang Province, People's Republic of China
| | - Xin-Lei Zhuang
- Pharmacy Department, Ningbo Medical Center Lihuili Hospital, Ningbo 315000, Zhejiang Province, People's Republic of China
| | - Qian-Meng Lin
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, People's Republic of China
| | - Da-Li Zeng
- Department of Pharmacy, Ruian Hospital of Traditional Chinese Medicine, Wenzhou 325000, Zhejiang Province, People's Republic of China
| |
Collapse
|
3
|
Soma LR, You Y, Robinson MA, Boston RC. Pharmacokinetics of intravenous, subcutaneous, and topical administration of lidocaine hydrochloride and metabolites 3-hydroxylidocaine, monoethylglycinexylidide, and 4-hydroxylidocaine in horse. J Vet Pharmacol Ther 2018; 41:825-837. [PMID: 30028024 DOI: 10.1111/jvp.12695] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Revised: 06/19/2018] [Accepted: 06/24/2018] [Indexed: 01/16/2023]
Abstract
Intravenous (iv), subcutaneous (sq), and topical (tp) lidocaine was administered to six horses in a cross-over, randomized design study. Samples were collected for up to 72 hr. Compartmental models were used to investigate the pharmacokinetics of (LD) and its metabolites 3-hydroxylidocaine (3-OH), 4-hydroxylidocaine (4-OH), and monoethylglycinexylidide (MEGX). Metabolites 3-OH and 4-OH were present in conjugated forms, whereas LD and metabolite MEXG were present primarily in the un-conjugated form. Plasma concentrations of LD after iv administration (100 mg) were described by three-compartment model with an additional three compartments to describe the elimination of metabolites. Median (range) elimination micro-constants (Ke ) for LD, 3-OH, 4-OH, and MEXG were 4.12 (2.62-6.23), 1.25 (1.10-2.15), 1.79 (1.22-2.39), and 1.69 (1.03-1.99)/hr, respectively. Median (range) values of alpha (t½α ), beta (t½β ), and gamma (t½γ ) half-lives were 0.08 (0.07-0.13), 0.57 (0.15-1.25), and 4.11 (0.52-7.36) hr. Plasma concentrations of LD after sq (200 mg) administration were described by absorption and two-compartment elimination model. The median (range) of the LD absorption half-life (t½ab ) was 0.47 (0.29-0.61) hr. The Ke for LD, 3-OH, 4-OH, and MEXG was 3.91 (1.48-9.25), 1.00 (0.78-1.08), 1.76 (0.96-2.11), and 1.13 (0.69-1.33)/hr. The median (range) of t½α and t½β was 0.15 (0.06-0.27) and 3.04 (2.53-6.39) hr. Plasma concentrations of LD after tp (400 mg) application were described by one-compartment model with a t½ab of 8.49 (5.16-11.80) hr. The Ke for LD, 3-OH, and MEXG was 0.24 (0.10-0.81), 0.41 (0.08-0.93), and 0.38 (0.26-1.14)/hr.
Collapse
Affiliation(s)
- Lawrence R Soma
- School of Veterinary Medicine, New Bolton Center Campus, University of Pennsylvania, Kennett Square, Pennsylvania
| | - Youwen You
- School of Veterinary Medicine, New Bolton Center Campus, University of Pennsylvania, Kennett Square, Pennsylvania.,Pennsylvania Equine Toxicology & Research Center, West Chester University, West Chester, Pennsylvania
| | - Mary A Robinson
- School of Veterinary Medicine, New Bolton Center Campus, University of Pennsylvania, Kennett Square, Pennsylvania.,Pennsylvania Equine Toxicology & Research Center, West Chester University, West Chester, Pennsylvania
| | - Raymond C Boston
- School of Veterinary Medicine, New Bolton Center Campus, University of Pennsylvania, Kennett Square, Pennsylvania
| |
Collapse
|
4
|
Doran GS, Smith AK, Rothwell JT, Edwards SH. Direct detection of glucuronide metabolites of lidocaine in sheep urine. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1076:84-90. [DOI: 10.1016/j.jchromb.2018.01.018] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2017] [Revised: 01/03/2018] [Accepted: 01/15/2018] [Indexed: 11/20/2022]
|
5
|
Pérez-Guaita D, Sánchez-Illana Á, Garrigues S, de la Guardia M. Determination of lidocaine in urine at low ppm levels using dispersive microextraction and attenuated total reflectance–Fourier transform infrared measurements of dry films. Microchem J 2015. [DOI: 10.1016/j.microc.2015.03.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
6
|
Lee H, Cima MJ. An intravesical device for the sustained delivery of lidocaine to the bladder. J Control Release 2010; 149:133-9. [PMID: 20971144 DOI: 10.1016/j.jconrel.2010.10.016] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2010] [Accepted: 10/14/2010] [Indexed: 10/18/2022]
Abstract
Intravesical instillation is a single compartment therapy providing high drug concentration at the bladder and reduced systemic exposure. Therapies based on this method, however, often require repeated instillations with intermittent transurethral catheterizations due to the short drug residence time in the bladder. Here we describe an intravesical device to achieve extended and localized delivery of lidocaine to the bladder. The device is a non-resorbable system that can be non-surgically deployed into the bladder. An in vivo rabbit study showed that lidocaine concentration in the bladder tissue was higher than 0.1μg/g during the 3 day period of device release while a single instillation yielded immeasurable amounts within 24h. The device can be used for the delivery of other therapeutic agents, currently delivered to the bladder by intravesical instillations.
Collapse
Affiliation(s)
- Heejin Lee
- Department of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Rm 12-096, Cambridge, MA 02139, USA
| | | |
Collapse
|
7
|
Nelis SA, Sievers C, Jarrett M, Nissen LM, Kirkpatrick CM, Shaw PN. Quantitative analysis of lignocaine and metabolites in equine urine and plasma by liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878:2018-22. [DOI: 10.1016/j.jchromb.2010.05.042] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2010] [Revised: 05/21/2010] [Accepted: 05/26/2010] [Indexed: 10/19/2022]
|
8
|
MacDougall LM, Hethey JA, Livingston A, Clark C, Shmon CL, Duke-Novakovski T. Antinociceptive, cardiopulmonary, and sedative effects of five intravenous infusion rates of lidocaine in conscious dogs. Vet Anaesth Analg 2009; 36:512-22. [DOI: 10.1111/j.1467-2995.2009.00480.x] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Joyce C, Smyth WF, Ramachandran VN, O'Kane E, Coulter DJ. The characterisation of selected drugs with amine-containing side chains using electrospray ionisation and ion trap mass spectrometry and their determination by HPLC–ESI-MS. J Pharm Biomed Anal 2004; 36:465-76. [PMID: 15522519 DOI: 10.1016/j.jpba.2004.07.026] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2004] [Revised: 07/13/2004] [Accepted: 07/15/2004] [Indexed: 11/29/2022]
Abstract
The electrospray ionisation-ion-trap mass spectrometry (ESI-MS(n)) of selected drug compounds with amine-containing side chains has been investigated. Certain characteristic in-source fragmentations have been observed for these molecules. Sequential product ion fragmentation experiments (MS(n)) have been performed in order to elucidate the degradation pathways for the [M + H](+) ions and their predominant fragment ions. These MS(n) experiments also show certain characteristic fragmentations with respect to the amine-containing side chains. QTOF-MS/MS has been used to support the identity of the proposed fragments. The data presented in this paper therefore provides useful information on the structure of these compounds with amine-containing side chains and can be used in the characterisation of such drugs, their structurally related metabolites and unknown molecules of pharmaceutical significance extracted from animal and plant sources, for example. Amphetamine, clenbuterol, flurazepam and methadone can be identified and determined in mixtures at low ng/ml concentrations by the application of HPLC-ESI-MS which can also be used for their analysis in saliva samples.
Collapse
Affiliation(s)
- Clare Joyce
- School of Biomedical Sciences, University of Ulster, Coleraine BT521SA, Northern Ireland, UK
| | | | | | | | | |
Collapse
|
10
|
|
11
|
National Horsemen's Benevolent & Protective Association, Inc proposed National Policy on Drug Testing and Therapeutic Medication. J Equine Vet Sci 2003; 23:18-40. [DOI: 10.1016/s0737-0806(03)70081-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|